Clinical Trials Browser

NCT05741242 2026-01-15

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Phase 1/2 Enrolling by invitation

136 enrolled

Tumor-Agnostic

Neoplasms

NCT05570994 2026-01-08

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Phase 1/2 Enrolling by invitation

50 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05893654 2025-09-15

MELCOM

Phase 1/2 Enrolling by invitation

10 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT05385861 2025-08-15

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

Phase 1/2 Enrolling by invitation

52 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT06027879 2025-06-25

Gamma Capture

Phase 1/2 Enrolling by invitation

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06768268 2025-04-16

ICGMV

Phase 1/2 Enrolling by invitation

30 enrolled

Breast

Breast Neoplasms

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

100 enrolled

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT01868490 2025-02-10

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Phase 1/2 Enrolling by invitation

20 enrolled

CNSGastrointestinal

Neuroblastoma, Cholangiocarcinoma

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

60 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00900497 2024-12-04

A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers

Phase 1/2 Enrolling by invitation

29 enrolled

Graft vs Host Disease